Table 1.
Baseline clinical characteristics of analyzed cohort according to PLR values.
Variable | 1st tertile, (n = 986) | 2nd tertile, (n = 986) | 3rd tertile, (n = 987) | P value | |
---|---|---|---|---|---|
Age (yrs) | 62.0 [56.0 ÷ 69.0] | 65.0 [57.0 ÷ 71.0] | 65.0 [58.0 ÷ 72.0] | <0.01 | |
Men (%) | 746 (75.7%) | 693 (70.3%) | 655 (66.4%) | <0.01 | |
Heart failure | NYHA class I/II | 107 (10.9%) | 93 (9.4%) | 101 (10.2%) | 0.70 |
NYHA class III/IV | 33 (3.3%) | 42 (4.3%) | 40 (4.1%) | ||
Atrial fibrillation | 104 (10.5%) | 106 (10.8%) | 110 (11.1%) | 0.91 | |
Hypertension | 698 (70.8%) | 686 (69.6%) | 740 (75.0%) | 0.02 | |
Previous MI | 578 (58.6%) | 562 (57.0%) | 589 (59.7%) | 0.48 | |
Previous CABG | 136 (13.8%) | 134 (13.6%) | 108 (10.9%) | 0.11 | |
Previous PCI | 460 (46.9%) | 485 (49.4%) | 504 (51.1%) | 0.17 | |
Previous SCD | 28 (2.8%) | 31 (3.1%) | 26 (2.6%) | 0.79 | |
PVD | 66 (6.7%) | 48 (4.9%) | 54 (5.5%) | 0.20 | |
Prev. Stroke/TIA | 39 (4.0%) | 47 (4.8%) | 46 (4.7%) | 0.64 | |
Diabetes mellitus | 366 (37.1%) | 344 (34.9%) | 365 (37.0%) | 0.51 | |
Lipid abnormalities | 576 (58.4%) | 564 (57.2%) | 544 (55.1%) | 0.33 | |
COPD | 68 (6.9%) | 71(7.2%) | 76 (7.7%) | 0.79 | |
Obesity | 328 (36.5%) | 300 (33.3%) | 264 29.1 (%) | <0.01 | |
Current smoker | 144 (14.6%) | 97 (9.9%) | 89 (9.0%) | <0.01 | |
Previous smoker | 376 (38.2%) | 356 (36.2%) | 343 (34.8%) | ||
FH of premature | 87 (8.8%) | 96 (9.8%) | 87 (8.8%) | 0.71 | |
CCS class | I/II | 826 (83.8%) | 821 (83.3%) | 832 (84.3%) | 0.82 |
III/IV | 160 (16.2%) | 165 (16.7%) | 155 (15.7%) | ||
In sinus rhythm at admission | 64 (6.5%) | 54 (5.5%) | 59 (6.0%) | 0.63 | |
Ejection fraction (%) | 48.0 [40.0 ÷ 53.5] | 48.0 [40.0 ÷ 55.0] | 50.0 [42.0 ÷ 55.0] | 0.08 | |
BMS | 582 (59.0%) | 529 (53.7%) | 535 (54.2%) | 0.11 | |
DES | 368 (37.3%) | 417 (42.3%) | 417 (42.2%) | ||
BMS + DES | 36 (3.7%) | 40 (4.1%) | 35 (3.5%) | ||
MVD | 194 (19.7%) | 189 (19.2%) | 196 (19.9%) | 0.92 | |
No. of PCI vessels | 1 | 786 (79.7%) | 781 (79.2%) | 791 (80.1%) | 0.60 |
No. of PCI vessels | 2 | 166 (16.8%) | 176 (17.8%) | 168 (17.0%) | |
No. of PCI | 3 | 34 (3.0%) | 29 (2.7%) | 28 (2.3%) | |
No. of stents | 1 | 715 (72.5%) | 678 (68.8%) | 679 (68.8%) | 0.62 |
No. of stents | 2 | 212 (21.5%) | 246 (24.9%) | 241 (24.4%) | |
No. of stents | 3 | 48 (4.9%) | 54 (5.5%) | 58 (5.9%) | |
⩾4 | 10 (0.7%) | 8 (0.7%) | 9 (0.7%) | ||
BMI | 28.4 [26.0÷31.3] | 28.0 [25.3÷30.8] | 27.7 [25.2÷30.5] | <0.01 |
Abbreviations: BMI - body mass index, BMS – bare metal stent, CABG – coronary artery bypass grafting, CCS – Canadian Cardiovascular Society, COPD - chronic obstructive pulmonary disease, DES – drug-eluting stent, FH – family history, MI – myocardial infarction, MVD – multivessel disease, NYHA – New York Heart Association, PCI – percutaneous coronary intervention, PVD – peripheral vascular disease, SCD - sudden cardiac death, TIA - transient ischemic attack.